Edition:
United States

Flexion Therapeutics Inc (FLXN.OQ)

FLXN.OQ on NASDAQ Stock Exchange Global Market

23.96USD
13 Aug 2018
Change (% chg)

-- (--)
Prev Close
$23.96
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
166,517
52-wk High
$32.22
52-wk Low
$19.07

Chart for

About

Flexion Therapeutics, Inc. is a United States-based specialty pharmaceutical company. The Company is focused on the development and commercialization of local therapies for the treatment of patients with musculoskeletal conditions, beginning with osteoarthritis (OA), a type of degenerative arthritis. The Company's lead product... (more)

Overall

Beta: 0.73
Market Cap(Mil.): $831.78
Shares Outstanding(Mil.): 37.64
Dividend: --
Yield (%): --

Financials

  FLXN.OQ Industry Sector
P/E (TTM): -- 189.67 32.45
EPS (TTM): -4.72 -- --
ROI: -49.31 1.41 12.93
ROE: -87.51 0.54 15.12

BRIEF-Flexion Therapeutics Q1 Loss Per Share $1.10

* FLEXION THERAPEUTICS REPORTS FIRST-QUARTER 2018 FINANCIAL RESULTS AND RECENT BUSINESS HIGHLIGHTS

May 08 2018

BRIEF-Flexion Therapeutics Names David Arkowitz As Chief Financial Officer

* FLEXION THERAPEUTICS NAMES DAVID ARKOWITZ AS CHIEF FINANCIAL OFFICER

May 07 2018

BRIEF-Flexion Therapeutics Reports Q4 Sales $355,000

* FLEXION THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

Mar 08 2018

Earnings vs. Estimates